Hospital Mater DeiBSP:MATD3 +3.18%85 Pretax Margin % is 8.89% as of Mar. 2026, which is 28% below its 10-year median of 12.43. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.85 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Hospital Mater Dei ranks better than 67.37% on this metric.
The historical rank and industry rank for Hospital Mater Dei's Pretax Margin % or its related term are showing as below:
BSP:MATD3'
s Pretax Margin % Range Over the Past 10 Years
Min: -22.4 Med: 12.43 Max: 30.39
Current: 8.35
BSP:MATD3's Pretax Margin % is ranked better than 67.37% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 3.97
vs BSP:MATD3: 8.35
Hospital Mater Dei (BSP:MATD3) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Hospital Mater Dei Pretax Margin % Related Terms
Hospital Mater Dei Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:MATD3 vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei (BSP:MATD3) has a Pretax Margin % of 8.89% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Hospital Mater Dei and its competitors. This is 28% below median its historical median of 12.43. According to the industry distribution chart, Hospital Mater Dei ranks #218 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 32.6%.
Is Hospital Mater Dei's Pretax Margin % too high?
Hospital Mater Dei's current Pretax Margin % of 8.89% is 28% below median its 10-year median of 12.43. The Healthcare Providers & Services industry median Pretax Margin % is 3.97. Hospital Mater Dei's value of 8.89% is 123.9% above this industry median. Based on the distribution chart, Hospital Mater Dei ranks #218 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #218 out of 668 companies for Pretax Margin %. This puts Hospital Mater Dei in the upper half of its industry. The industry median Pretax Margin % is 3.97. Hospital Mater Dei's value of 8.89% is 123.9% above this benchmark. While the company's 10-year median is 12.43 vs. the industry median of 3.97, Hospital Mater Dei has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 3.97, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current Pretax Margin % of 8.89% is 123.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 3.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current Pretax Margin % is 8.89%, which is 28% below median its own 10-year median of 12.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.85, compared to a current price of R$4.86 — trading 16.9% below its estimated fair value. The current Pretax Margin % is 8.89%, which is 28% below median its 10-year median of 12.43 and 123.9% above the Healthcare Providers & Services industry median of 3.97. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Pretax Margin % is 8.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.86 is trading 16.9% below its estimated GF Value™ of R$5.85.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
Pretax Margin %: 8.89% (28% below median its 10-year median of 12.43)
GF Value™: R$5.85 vs. price of R$4.86 (16.9% below fair value)
Industry Position: 123.9% above the Healthcare Providers & Services median (#218 of 668)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score
Get the complete analysis for BSP:MATD3
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
